A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/30/2006	US20060270852 Preparation of bisquinoline compounds
11/30/2006	US20060270848 Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of gonadotropin releasing hormone receptor
11/30/2006	US20060270829 G-csf conjugates
11/30/2006	US20060270742 Compositions and methods for the treatment of neurodegenerative diseases
11/30/2006	US20060270741 Pharmaceutically active compounds and methods of use
11/30/2006	US20060270740 Prostaglandin derivatives
11/30/2006	US20060270739 Increasing the absorption of dietary carotenoids in humans; used to increase the concentration of retinal lutein and zeaxanthin thereby preventing the onset and/or slowing the progression of macular degeneration; improving memory and cognitive abilities
11/30/2006	US20060270738 Novel derivatives of 3,3-diphenylpropylamines
11/30/2006	US20060270736 Ternary and quaternary eutectic mixtures of local anesthetics substances
11/30/2006	US20060270735 Stable prostaglandin-containing compositions
11/30/2006	US20060270734 Benzo lipoxin analogues
11/30/2006	US20060270733 2-Aminobenzoyl derivatives
11/30/2006	US20060270732 Antioxidant supplement compostion and method of use
11/30/2006	US20060270731 Pure duloxetine hydrochloride
11/30/2006	US20060270730 Histone deacetylase inhibitors as immunosuppressants
11/30/2006	US20060270729 Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
11/30/2006	US20060270728 Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/30/2006	US20060270727 Small molecule therapeutics and uses therefor
11/30/2006	US20060270725 N[S(4-aryl-triazol-3-yl)alpha-mercaptoacetyl]-p-amino benzoic acids as HIV reverse transcriptase inhibitors
11/30/2006	US20060270724 3-[p-(substituted benzyloxy)- or p-(substituted -5-thiazolylmethoxy)phenyl]propionic acid derivatives in which the propionic acid is 3-substituted with a carbamoyl-, imidazolyl-, triazolyl-, tetrazolyl-, or oxazolyl group; activating G-protein coupled receptor 40; treatment of type II diabetes
11/30/2006	US20060270723 Process for preparing amorphous valsartan
11/30/2006	US20060270722 Combination of a dipeptidyl peptidase-IV inhibitor and a dual PPAR agonist for the treatment of diabetes and obesity
11/30/2006	US20060270721 EP4 receptor agonist, compositions and methods thereof
11/30/2006	US20060270720 Iminothiazolidinone derivatives as SFRP-1 antagonists
11/30/2006	US20060270719 2-[(Cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-2-yl-benzyl)-amino]-N-hydroxy-acetamide; selective inhibitors of matrix-degrading metalloproteinases, especially MT1-MMP, MMP-2 and MMP-9; Osteoporosis; Antitumor, antiproliferative agents
11/30/2006	US20060270718 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia
11/30/2006	US20060270717 Therapeutic combination
11/30/2006	US20060270716 Method for treating osteoarthritis
11/30/2006	US20060270715 Dosage forms of amlodipine and processes for their preparation
11/30/2006	US20060270714 Novel n-substituted 2-aminopyridine derivatives
11/30/2006	US20060270713 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/30/2006	US20060270712 contains 4-[ alpha -hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoic acid; prophylaxis, hypomyelination, dysmyelination or demyelination; myelin-associated glycoprotein (MAG)
11/30/2006	US20060270711 Tenatoprazole salts and process of preparation thereof
11/30/2006	US20060270710 Methods for inhibition of angiogenesis
11/30/2006	US20060270709 Dihydropyridine compounds and compositions for headaches
11/30/2006	US20060270708 Novel process for preparation of isotonic aqueous injection of ropivacaine
11/30/2006	US20060270707 Methods and compositions using 4-[(cyclopropanecarbonylamino)methyl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione for the treatment or prevention of cutaneous lupus
11/30/2006	US20060270706 Cyclic amine derivative having heteroaryl ring
11/30/2006	US20060270705 Method for inhibiting lipid absorption and lipid absorption inhibitor
11/30/2006	US20060270704 potassium channel modulators such as 4-(3-fluorophenyl)-6-methoxy-N,N,2-trimethyl-1-oxo-1,2-dihydroisoquinoline-3-carboxamide, used as antiarrhythmia agents; cardiovascular disorders
11/30/2006	US20060270703 G-csf conjugates
11/30/2006	US20060270702 Certain substituted ureas, as modulators of kinase activity
11/30/2006	US20060270701 Dipeptidyl peptidase-IV inhibitors
11/30/2006	US20060270700 Potentiation of antineoplastic agents using sigma-2 ligands
11/30/2006	US20060270699 Stabilization of hypoxia inducible factor (HIF) alpha
11/30/2006	US20060270698 Scopolamine for the treatment of depression and anxiety
11/30/2006	US20060270697 Treatment method
11/30/2006	US20060270696 1,3,8-triazaspiro(4,5)decane derivatives; antiinflammatory agent for treating rheumatoid arthritis, allergic, multiple sclerosis, autoimmune disease such as inflammatory bowel disease
11/30/2006	US20060270695 Spirocyclic heterocyclic derivatives and methods of their use
11/30/2006	US20060270694 JAK kinase inhibitors and their uses
11/30/2006	US20060270693 Ether derivative
11/30/2006	US20060270692 2-(4-{[7-(3-chloropropoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-1-yl)-N-(3-fluorophenyl)acetamide; colorectal cancer
11/30/2006	US20060270691 Purine derivatives as purinergic receptor antagonists
11/30/2006	US20060270690 N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto
11/30/2006	US20060270689 Novel Fused Heterocycles and Uses Thereof
11/30/2006	US20060270688 Compounds for modulating TRPV3 function
11/30/2006	US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006	US20060270686 Anti-cancer agents and uses thereof
11/30/2006	US20060270685 Anhydrous ziprasidone mesylate and a process for its preparation
11/30/2006	US20060270684 Crystalline forms of ziprasidone mesylate
11/30/2006	US20060270683 Polymorphs of aripiprazole
11/30/2006	US20060270682 Substituted Aryloxymethyl Bicyclicmethyl Acetamide Compounds
11/30/2006	US20060270681 Pyridazine derivatives
11/30/2006	US20060270680 Sulfonamide compounds and methods of making and using the same
11/30/2006	US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/30/2006	US20060270678 Pyrrolopyridazine derivatives
11/30/2006	US20060270677 Method for the treatment of noise phobia in companion animals
11/30/2006	US20060270676 Hydrazono-malonitriles
11/30/2006	US20060270675 Inhibitors of cholesterol ester transfer protein
11/30/2006	US20060270674 Pharmaceutical composition promoting defecation
11/30/2006	US20060270673 Inhibitors of akt activity
11/30/2006	US20060270672 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
11/30/2006	US20060270671 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
11/30/2006	US20060270670 Methods of synthesizing 6-alkylaminoquinoline derivatives
11/30/2006	US20060270669 Method of preparing 3-cyano-quinolines and intermediates made thereby
11/30/2006	US20060270668 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
11/30/2006	US20060270667 Novel medicament combinations for the treatment of respiratory diseases
11/30/2006	US20060270666 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
11/30/2006	US20060270665 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity
11/30/2006	US20060270664 Fluorescent fused-ring triazoles that inhibit cell proliferation and uses thereof
11/30/2006	US20060270663 tyrosine kinase inhibitors such as N-[4-(4-amino-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepin-6-yl)phenyl]-N'-phenylurea, used for treating benign or neoplastic proliferative diseases and autoimmune diseases; antitumor agents
11/30/2006	US20060270662 Methods for administration of a farnesyl dibenzodiazepinone
11/30/2006	US20060270661 Pyrrolobenzodiazepines
11/30/2006	US20060270660 Processes for preparing substituted pyrimidines
11/30/2006	US20060270659 Pyrazolopyrimidines as CRF receptor antagonists
11/30/2006	US20060270658 Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
11/30/2006	US20060270657 N-substituted heterocyclic sulfonamides
11/30/2006	US20060270656 Substituted piperazines of azepines, oxazepines and thiazepines
11/30/2006	US20060270655 Combination therapy for treating obesity or maintaining weight loss
11/30/2006	US20060270654 1,6-Dihydro-1,3,5,6-Tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
11/30/2006	US20060270653 such as 1-(1'-(1-methylcyclohexyl)-1H-spiro[isoquinoline-4,4'-piperidine]-2(3H)-yl)ethanone, used for the treatment of vision defects, nervous system, psychological, gastrointestinal, genetic and muscular disorders, or as wound healing agents
11/30/2006	US20060270652 Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
11/30/2006	US20060270651 Antibacterial agents
11/30/2006	US20060270650 Combination therapy for the treatment of obesity
11/30/2006	US20060270649 Azetidine derivatives, their preparation and medicaments containing them
11/30/2006	US20060270648 Use of polyamines with antibiotics
11/30/2006	US20060270647 Glutamate agents in the treatment of mental disorders
11/30/2006	US20060270646 Jnk inhibitors
11/30/2006	US20060270645 Agents and methods for enhancing bone formation
11/30/2006	US20060270644 Nitrate esters of corticoid compounds and pharmaceutical applications thereof

1 ... 3985 3986 3987 3988 3989 3990 3991 3992 3993 3994 3995 3996 3997 3998 3999 4000 4001 4002 4003 4004 4005 ... 7860